587 related articles for article (PubMed ID: 20442590)
1. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
2. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
4. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
6. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
7. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.
Sellors JW; Schweizer JG; Lu PS; Liu B; Weigl BH; Cui JF; Peck RB; Lewis K; Lim J; Howard M; Mahoney CW; McAllister L; Berard-Bergery M; Bry C; Labiad YA; Li H; Liu L; Silver J; Chen W; Qiao YL
J Low Genit Tract Dis; 2011 Apr; 15(2):169-76. PubMed ID: 21478701
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles are altered in human papillomavirus-16 E6 D25E-expressing cell lines.
Jang M; Rhee JE; Jang DH; Kim SS
Virol J; 2011 Sep; 8():453. PubMed ID: 21943319
[TBL] [Abstract][Full Text] [Related]
9. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.
Piyathilake CJ; Macaluso M; Alvarez RD; Chen M; Badiga S; Edberg JC; Partridge EE; Johanning GL
Cancer; 2011 Mar; 117(5):957-63. PubMed ID: 20945322
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
11. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
[TBL] [Abstract][Full Text] [Related]
12. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
Au Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
[TBL] [Abstract][Full Text] [Related]
14. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
[TBL] [Abstract][Full Text] [Related]
15. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
Wang X; Meyers C; Guo M; Zheng ZM
Int J Cancer; 2011 Sep; 129(6):1362-72. PubMed ID: 21128241
[TBL] [Abstract][Full Text] [Related]
17. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
[TBL] [Abstract][Full Text] [Related]
18. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts.
Häfner N; Driesch C; Gajda M; Jansen L; Kirchmayr R; Runnebaum IB; Dürst M
Oncogene; 2008 Mar; 27(11):1610-7. PubMed ID: 17828299
[TBL] [Abstract][Full Text] [Related]
19. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.
Li BH; Zhou JS; Ye F; Cheng XD; Zhou CY; Lu WG; Xie X
Eur J Cancer; 2011 Sep; 47(14):2166-74. PubMed ID: 21636267
[TBL] [Abstract][Full Text] [Related]
20. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
